Dr Justin Davies (London, UK) and Dr David Kandzari (Atlanta, US) discuss the SPYRAL HTN-ON MED study and how it will affect treatment of hypertension.

Filmed by Radcliffe Cardiology on-site at EuroPCR 2018 in Paris, FR.

Funding to produce this video was provided by an unrestricted grant from: